TIM MIRUS Controller - Device Safety Aspects

2 Safety
IFU, MIRUS Controller, en-GB, N.00 15
2.3.7 MDI Applications
WARNING Using MDI applications with the MIRUS System can result in an
underdosage of the patient for a short period of time.
2.3.8 Resistance of airway components
WARNING Never use an active humidification system when operating the MIRUS
System. This may result in serious increase of airway resistance.
When using the MIRUS System with an anaesthesia workstation,
never adjust the fresh gas setting to low-flow values (< 1.5 x MV). The
CO
2
absorption process in the rebreathing circuit may generate heat
and moisture. This may result in serious increase of airway resistance.
Always monitor for possible increase in airway resistance.
2.4 User’s and other patient’s safety
WARNING You will work with volatile anaesthetic agents. To protect yourself and
others, observe the volatile anaesthetic agent manufacturer’s safety
instructions for handling with volatile anaesthetic agents.
Turn off volatile anaesthetic agent delivery when disconnecting the
patient’s breathing system to avoid ambient pollution.
Do not use the MIRUS System in parallel to extracorporeal membrane
oxygenation (ECMO) or extracorporeal membrane decarboxylation
(ECOR).
2.5 Device
2.5.1 Accessories
WARNING Use only accessories approved by the manufacturer of either the
MIRUS Controller or the accessory.